Objectives: The SARS-CoV-2 BQ.1* variant rapidly spread globally in late 2022, posing a challenge due to its increased immune evasion.
Methods: We conducted a prevalence survey in Brazil from November 16 to December 22, 2022, as part of a cohort study.